review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1002/1520-7560(2000)9999:9999<::AID-DMRR145>3.0.CO;2-L |
P698 | PubMed publication ID | 11025558 |
P2093 | author name string | Potter KN | |
Wilkin TJ | |||
P2860 | cites work | The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus | Q24647015 |
Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies | Q28237011 | ||
One-megabase sequence analysis of the human immunoglobulin lambda gene locus | Q28306323 | ||
Functional diversity of helper T lymphocytes | Q29619415 | ||
Type I diabetes mellitus. A chronic autoimmune disease | Q34181699 | ||
Organization of the human immunoglobulin lambda light-chain locus on chromosome 22q11.2. | Q34303713 | ||
Autoantibodies against human insulin | Q34555621 | ||
Autoimmune diabetes and the germ theory of disease | Q35225964 | ||
Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects | Q35296645 | ||
Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin Treatment | Q70311233 | ||
Resting B cells can act as antigen presenting cells in vivo and induce antibody responses | Q70585065 | ||
Antigen based therapies to prevent diabetes in NOD mice | Q71557201 | ||
Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes | Q71557208 | ||
The MoAb-V kappa IIIb cross-reactive idiotope on A27a (Humkv325) encoded kappa chains maps to framework region 3. off | Q71623420 | ||
Immunogenetic Determinants and Prediction of IDDM in French Schoolchildren | Q72015344 | ||
Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease | Q72134560 | ||
HLA antigens and age at diagnosis of insulin-dependent diabetes mellitus | Q72222910 | ||
T helper cell subsets in insulin-dependent diabetes | Q72265872 | ||
Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives | Q72717711 | ||
A long-term longitudinal isotypic study of anti-topoisomerase I autoantibodies | Q72968197 | ||
Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome | Q73820087 | ||
A novel micro-assay for insulin autoantibodies | Q73893605 | ||
Preference for IgG mAb binding insulin in solution or on surfaces is related to immunoglobulin variable region structures | Q74125797 | ||
Costs of predicting IDDM | Q74303154 | ||
Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study | Q74607777 | ||
Anti-idiotypic antibody D12 and superantigen SPA both interact with human VH3-encoded antibodies on the external face of the heavy chain involving FR1, CDR2 and FR3 | Q77310871 | ||
Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice | Q77488356 | ||
Epitope spreading: the role of self peptides and autoantigen processing by B lymphocytes | Q77488392 | ||
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop | Q77628562 | ||
Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus | Q35612872 | ||
Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. | Q36353954 | ||
B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice | Q36367653 | ||
Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus | Q36380697 | ||
Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens | Q36380993 | ||
Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells | Q37367625 | ||
Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice | Q37372373 | ||
Role of viruses in the pathogenesis of IDDM. | Q37421841 | ||
Use of monoclonal antibodies to identify shared idiotypes on human antibodies to native DNA from patients with systemic lupus erythematosus | Q37603341 | ||
Insulin autoantibodies as markers for type I diabetes | Q37909546 | ||
Autoimmunity: attack, or defence? (The case for a primary lesion theory). | Q38219248 | ||
A simple, rapid ELISA method for the detection of DNA antibodies | Q39490503 | ||
Congenital rubella syndrome and diabetes: a review of epidemiologic, genetic, and immunologic factors | Q39806007 | ||
Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production | Q40344443 | ||
Molecular genetics of diabetes mellitus | Q40422438 | ||
Early environmental events as a cause of IDDM. Evidence and implications | Q40662621 | ||
Islet cell antigens in the prediction and prevention of insulin-dependent diabetes mellitus | Q40870952 | ||
NOD mouse colonies around the world--recent facts and figures | Q40920352 | ||
Molecular characterization of the VH1-specific variable region determinants recognized by anti-idiotypic monoclonal antibodies G6 and G8. | Q40942277 | ||
Effects of Human Insulin on Insulin Binding Antibody Production in Nondiabetic Subjects | Q41142661 | ||
Theory and practice of nicotinamide trials in pre-type 1 diabetes | Q41184046 | ||
The cross-reactive idiotopes recognized by the monoclonal antibodies 9G4 and LC1 are located in framework region 1 of two non-overlapping subsets of human VH4 family encoded antibodies | Q41456692 | ||
Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus | Q41465592 | ||
Epitope-directed processing of specific antigen by B lymphocytes | Q41572613 | ||
Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus | Q41579779 | ||
Germinal center development | Q41583265 | ||
Systemic antigen in the treatment of T-cell-mediated autoimmune diseases | Q41679018 | ||
Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments | Q41886151 | ||
Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland | Q46088274 | ||
HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus | Q46138865 | ||
Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis | Q46511634 | ||
Prevention of type 1 diabetes | Q47678735 | ||
Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay | Q47854218 | ||
Natural and disease associated autoantibodies to the autoantigen, dihydrolipoamide acetyltransferase, recognise different epitopes. | Q47896809 | ||
Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire | Q47994789 | ||
Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens | Q48021507 | ||
A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. | Q48082296 | ||
Insulin autoantibodies and insulin antibodies have similar binding characteristics. | Q52227031 | ||
Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International GADAB Workshop. | Q53375078 | ||
The second International Workshop on the Standardisation of Insulin Autoantibody (IAA) measurement. Held in New York, 27-30 October 1987. | Q53414373 | ||
Differences in epitope restriction of autoantibodies to native human insulin (IAA) and antibodies to heterologous insulin (IA). | Q53884125 | ||
Molecular mimicry between insulin and retroviral antigen p73. Development of cross-reactive autoantibodies in sera of NOD and C57BL/KsJ db/db mice. | Q54387671 | ||
Application of a rapid enzyme-linked immunosorbent microassay (ELISA) to study human anti-insulin antibody. | Q54459436 | ||
A new marker in the HLA class I region is associated with the age at onset of IDDM | Q56880554 | ||
Cross-presentation: a general mechanism for CTL immunity and tolerance | Q57228022 | ||
Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study | Q58037248 | ||
Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects | Q67963478 | ||
Insulin autoantibody polymorphisms with greater discrimination for diabetes in humans | Q68047457 | ||
A comparison of childhood and adult type I diabetes mellitus | Q69490662 | ||
Comparison of liquid phase radiobinding assay and solid phase ELISA for the measurement of insulin antibodies and insulin autoantibodies in serum | Q70023571 | ||
Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age | Q70247169 | ||
P433 | issue | 5 | |
P921 | main subject | autoantibody | Q785022 |
preproinsulin | Q7240673 | ||
P304 | page(s) | 338-353 | |
P577 | publication date | 2000-09-01 | |
P1433 | published in | Diabetes - Metabolism: Research and Reviews | Q15750056 |
P1476 | title | The molecular specificity of insulin autoantibodies | |
P478 | volume | 16 |
Q28363451 | Autoimmune type 1 diabetes: resolved and unresolved issues |
Q35080825 | Characterization of insulin antibodies by Surface Plasmon Resonance in two clinical cases: brittle diabetes and insulin autoimmune syndrome |
Q33215130 | Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies |
Q34477804 | Expansion of CD4+CD25+FOXP3+ regulatory T cells in infants of mothers with type 1 diabetes |
Q79267868 | Insulin autoantibody isotypes during the prediabetic process in young children with increased genetic risk of type 1 diabetes |
Q34001178 | Is it dietary insulin? |
Q28485499 | UV-light exposure of insulin: pharmaceutical implications upon covalent insulin dityrosine dimerization and disulphide bond photolysis |
Search more.